chr10-60391257-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000373827.6(ANK3):​c.97-111618G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.101 in 152,074 control chromosomes in the GnomAD database, including 1,129 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.10 ( 1129 hom., cov: 33)

Consequence

ANK3
ENST00000373827.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -3.50

Publications

11 publications found
Variant links:
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
  • intellectual disability-hypotonia-spasticity-sleep disorder syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • intellectual disability
    Inheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.25 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANK3NM_001204404.2 linkc.64-111618G>A intron_variant Intron 1 of 43 NP_001191333.1 Q12955-4
ANK3NM_001204403.2 linkc.97-111618G>A intron_variant Intron 2 of 43 NP_001191332.1 Q12955-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANK3ENST00000373827.6 linkc.97-111618G>A intron_variant Intron 2 of 43 1 ENSP00000362933.2 Q12955-5
ANK3ENST00000503366.6 linkc.64-111618G>A intron_variant Intron 1 of 43 2 ENSP00000425236.1 Q12955-4
ANK3ENST00000622427.4 linkn.64-111618G>A intron_variant Intron 1 of 32 2 ENSP00000483244.1 A0A087X0B4

Frequencies

GnomAD3 genomes
AF:
0.100
AC:
15264
AN:
151954
Hom.:
1116
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0949
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.206
Gnomad ASJ
AF:
0.0381
Gnomad EAS
AF:
0.262
Gnomad SAS
AF:
0.134
Gnomad FIN
AF:
0.178
Gnomad MID
AF:
0.0446
Gnomad NFE
AF:
0.0587
Gnomad OTH
AF:
0.0894
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.101
AC:
15308
AN:
152074
Hom.:
1129
Cov.:
33
AF XY:
0.108
AC XY:
8021
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.0953
AC:
3955
AN:
41502
American (AMR)
AF:
0.207
AC:
3160
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.0381
AC:
132
AN:
3462
East Asian (EAS)
AF:
0.261
AC:
1345
AN:
5150
South Asian (SAS)
AF:
0.132
AC:
633
AN:
4812
European-Finnish (FIN)
AF:
0.178
AC:
1880
AN:
10570
Middle Eastern (MID)
AF:
0.0442
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
0.0587
AC:
3989
AN:
67974
Other (OTH)
AF:
0.0937
AC:
198
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
650
1301
1951
2602
3252
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
170
340
510
680
850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.109
Hom.:
275
Bravo
AF:
0.104
Asia WGS
AF:
0.213
AC:
737
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.0030
DANN
Benign
0.68
PhyloP100
-3.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3808943; hg19: chr10-62151015; API